The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Anticoagulation of Pregnant Women With Mechanical Heart Valves: A Systematic Review of the Literature
Abstract
BACKGROUND: The management of women with prosthetic heart valves during pregnancy poses a particular challenge as there are no available controlled clinical trials to provide guidelines for effective antithrombotic therapy. Oral anticoagulants such as warfarin sodium cause fetal embryopathy; subcutaneous administration of heparin sodium has been reported to be ineffective in preventing thromboembolic complications. OBJECTIVE: To identify the risks of maternal and fetal complications in women with mechanical heart valves treated with different anticoagulation regimens during pregnancy. METHODS: We performed a systematic review of the literature to determine pooled estimates of maternal and fetal risks associated with the 3 commonly used approaches: (1) oral anticoagulants (OA) throughout pregnancy, (2) replacing OA with heparin in the first trimester (from 6-12 weeks' gestation), and (3) heparin use throughout pregnancy. Fetal outcomes included spontaneous abortions and fetopathic effects, and maternal outcomes were major bleeding, thromboembolic complications, and death. RESULTS: The use of OA throughout pregnancy is associated with warfarin embryopathy in 6.4% (95% confidence interval [CI], 4.6%-8.9%) of livebirths. The substitution of heparin at or prior to 6 weeks, and continued until 12 weeks, eliminated this risk. Overall risks for fetal wastage (spontaneous abortion, stillbirths, and neonatal deaths) were similar in women treated with OA throughout, compared with women treated with heparin in the first trimester. Maternal mortality was 2.9% (95% CI, 1.9%-4.2%). Maj or bleeding events occurred in 2.5% (95% CI, 1.7%-3.5%) of all pregnancies, most at the time of delivery. The regimen associated with the lowest risk of valve thrombosis (3.9%; 95% CI, 2.9-5.9%) was the use of OA throughout; using heparin only between 6 and 12 weeks' gestation was associated with an increased risk of valve thrombosis (9.2%; 95% CI, 5.9%-13.9%). CONCLUSIONS: Thromboembolic prophylaxis of women with mechanical heart valves during pregnancy is best achieved with OA; however, this increases the risk of fetal embryopathy. Substituting OA with heparin between 6 and 12 weeks reduces the risk of fetopathic effects, but with an increased risk of thromboembolic complications. The use of low-dose heparin is definitely inadequate; the use of adjusted-dose heparin warrants aggressive monitoring and appropriate dose adjustment. Large prospective trials to determine the best regimen for these women are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Vongpatanasin, W., Hillis, L. D., & Lange, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350607 · Cited by 811
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
Iturbe-Alessio, I., Fonseca, M. D. C., Mutchinik, O., Santos, M. A., Zajarías, A., & Salazar, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152205 · Cited by 307
Outcome of pregnancy in women with valve prostheses.
Sbarouni, E., & Oakley, C. M. (1994) · Heart · doi:10.1136/hrt.71.2.196 · Cited by 305
Nelson-Piercy, C., Letsky, E. A., & de Swiet, M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70403-4 · Cited by 260
Risks to the Fetus of Anticoagulant Therapy During Pregnancy
Ginsberg, J. S., Hirsh, J., Turner, D. C., Levine, M. N., & Burrows, R. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646558 · Cited by 218
Self-citationSalazar, E., Izaguirre, R., Verdejo, J., & Mutchinick, O. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00072-1 · Cited by 183
Born, D., Martinez, E. E., de Almeida, P. A. M., et al. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90606-v · Cited by 115
The problem of cardiac valve prostheses, anticoagulants, and pregnancy.
Salazar, E. J., Zajarías, A., Gutierrez, N., et al. (1984) · PubMed · Cited by 115
Pregnancy and Mechanical Valve Prostheses: A High-Risk Situation for the Mother and the Fetus
Larrea, J. L., Núñez, L., Reque, J. A., Aguado, M. G., Matarros, R., & Mínguez, J. Á. (1983) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)60488-2 · Cited by 81
Pregnancy in Patients with Prosthetic Heart Valves: An Experience with 45 Pregnancies
Chen, W. W. C., Chan, C., Lee, P., Wang, R. Y. C., & WONG, V. C. W. (1982) · QJM · doi:10.1093/oxfordjournals.qjmed.a067728 · Cited by 78
Follow‐up study of children whose mothers were treated with warfarin during pregnancy
CHONG, M. K. B., Harvey, D. R., & de Swiet, M. (1984) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb15077.x · Cited by 71
Pregnancy in patients after valve replacement.
Oakley, C. M., & Doherty, P. W. (1976) · Heart · doi:10.1136/hrt.38.11.1140 · Cited by 70
Pregnancy and its complications following cardiac valve prostheses
Lutz, D. J., Noller, K. L., Spittell, J. A., Danielson, G. K., & Fish, C. R. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90423-4 · Cited by 69
Lee, L. H., Liauw, P. C., & Ng, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650634 · Cited by 61
Pregnancy in patients with prosthetic cardiac valve:A 10-Year Experience
Pavankumar, P., Venugopal, P. S., Kaul, U., et al. (1988) · Scandinavian Journal of Thoracic and Cardiovascular Surgery · doi:10.3109/14017438809106045 · Cited by 60
The course of pregnancy in patients with artificial heart valves
Ibarra-Pérez, C., Arévalo, N., de la Cadena, O. A., & Noriega-Guerra, L. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90330-2 · Cited by 57
Pregnancy and prosthetic heart valves
Ginsberg, J. S., & Barron, W. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90501-0 · Cited by 54
Self-citationLee, P.-K., Wang, R. Y. C., Chow, J. S. F., Cheung, K., WONG, V. C. W., & Chan, T.-K. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80116-4 · Cited by 51
Cardiac valve prostheses, anticoagulation, and pregnancy.
Ismail, M. B., Abid, F., Trabelsi, S., Taktak, M., & Fekih, M. (1986) · Heart · doi:10.1136/hrt.55.1.101 · Cited by 50
Cardiac Valve Prostheses, Anticoagulation, and Pregnancy
Limet, R., & Grondin, C. M. (1977) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)64137-9 · Cited by 44
Cardiovascular management of pregnant women with a heart valve prosthesis
Pablo Casanegra, P., Avilés, G., Gustavo Maturana, B., & Juan Dubernet, M. (1975) · The American Journal of Cardiology · doi:10.1016/0002-9149(75)90463-4 · Cited by 35
Wang, R. Y. C., Lee, P. K., Chow, J. S. F., & Chen, W. W. C. (1983) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1983.tb122360.x · Cited by 35
Vitali, E., Donatelli, F., Quaini, E., Groppelli, G., & Pellegrini, A. (1986) · PubMed · Cited by 32
Pregnancy and its complications after cardiac valve replacement
Ayhan, A., Yapar, E. G., Yuce, K., Kişnişçi, H. A., Nazlı, N., & Özmen, F. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90813-k · Cited by 29
Palacios-Macedo, X., Díaz-Devis, C., & Escudero, J. (1969) · The American Journal of Cardiology · doi:10.1016/0002-9149(69)90475-5 · Cited by 27
Pregnancy after heart valve replacement
Javares, T., Coto, E. O., Maiques, V., Rincon, A., Such, M., & Caffarena, J. M. (1984) · International Journal of Cardiology · doi:10.1016/0167-5273(84)90221-3 · Cited by 22
Pregnancy in patients with prosthetic cardiac valves.
Guidozzi, F. (1984) · PubMed · Cited by 21
Problems in the management of patients with artificial valves during pregnancy
O'NEILL, H., Blake, S., SUGRUE, D. D., & MacDonald, D. (1982) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1982.tb05062.x · Cited by 20
Pregnancy outcome in women with cardiac valve prosthesis
Caruso, A., Carolis, S. D., Ferrazzani, S., Paradisi, G., Pomini, F., & Pompei, A. (1994) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)90074-4 · Cited by 15
Pregnancy in 6 patients with starr-edwards heart valve prostheses
Ibarra-Pérez, C., & del Bosque-Ruiz, M. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90051-3 · Cited by 13
Hurwitz, A., Milwidsky, A., Medina, A. E., & Yagel, S. (1985) · PubMed · Cited by 10
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Metadata
- Authors
- Chan, W. S., Anand, S., & Ginsberg, J. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-01-24
- Volume
- 160
- Issue
- 2
- Pages
- 191
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2138444098
- Cited by
- 749
- References
- 34
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.